secwatch.observer — SEC 8-K summary
======================================

Issuer:     MEDIFAST INC (MED)
CIK:        0000910329
Form:       8-K
Filed at:   2025-04-28T23:59:59+00:00
Accession:  0001628280-25-020336
Event type: earnings
Sentiment:  negative
Materiality: 0.85
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Medifast Q1 2025: revenue down 34% to $115.7M, net loss $0.8M; Q2 guidance weak
-------------------------------------------------------------------------------

- Revenue fell 33.8% to $115.7M; active earning coaches down 32.8% to 25,400.
- Net loss of $0.8M vs. net income of $8.3M a year ago; diluted EPS -$0.07.
- Gross margin held at 72.8%; operating loss $1.3M vs. operating income $7.9M.
- Q2 2025 revenue guidance $85M-$105M; loss per share $0.00-$0.55.
- Cash, equivalents, and investments $164.6M; no debt.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/910329/000162828025020336/0001628280-25-020336-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/910329/000162828025020336/med-20250428.htm
  HTML page:      https://secwatch.observer/filing/0001628280-25-020336

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer